Tag:
Sigma Pharmaceuticals
Latest Headlines
Latest Headlines
Warehouse strike creates drug shortages in Australia
Not all drug shortages are tied to manufacturing problems. In Melbourne, Australia, Sigma Pharmaceuticals has asked officials to step in and mediate to end a strike at a warehouse that is slowing the delivery of drugs to pharmacies.
Aspen Pharmacare eyes another $800M in M&A
South Africa's Aspen Pharmacare has posted some strong full-year sales and profits growth, thanks in part to expansion outside its home market. Part of that growth came from its $879 million
Sigma, API shares fall after Pfizer reveals Australian distribution model
Pfizer's decision to sell drugs to pharmacies rather than use Australian wholesalers has sent the share price of the country's leading wholesalers into a tailspin. Sigma Pharmaceuticals' shares down
Aspen nabs Sigma's drug biz for $804M
Sigma Pharmaceuticals was playing its cards close to the vest last week when it denied a higher buyout offer from South Africa's Aspen Pharmacare. Aspen might not have hiked its offer for the entire
Sigma denies sweetened buyout bid from Aspen
Sigma Pharmaceuticals denied Australian media reports that Aspen Pharmacare Holdings had boosted its buyout offer for the company to 65 cents per share, or $689 million; Aspen's formal bid made last
Report: Watson flirts with Sigma offer
Sigma Pharmaceuticals is reportedly getting a new suitor. The Australian drugmaker has caught the eye of U.S.-based Watson Pharmaceuticals, which is working to expand its presence overseas. Watson
With Aspen circling, Sigma gets piecemeal bids
Australia's Sigma Pharmaceuticals ( SIP.AX ) has received three bids for its Herron drugs arm and three bids for its Orphan Australia drugs business, as it seeks an improved bid for the entire company
Aspen drops Sigma bid by 8 percent
As analysts predicted, Aspen Pharmacare cut its buyout offer for Sigma Pharmaceuticals--to $552 million, an 8 percent drop--raising questions about whether a deal might actually happen. Report
Aspen likely to cut $596M offer for Sigma
Now that Aspen Pharmacare has had a look at Sigma Pharmaceuticals' books, it's not as enamored with the Australian drugmaker. Sources tell Bloomberg that Aspen now plans to reduce its A$707 million
Aspen-Sigma deal would create No. 1 Aussie drugmaker
While Abbott Laboratories was capturing headlines for its acquisition of a chunk of India's Piramal, a Southern Hemisphere deal took aim at the top spot in Australia's prescription drug market.
